Is Jyothy Labs overvalued or undervalued?

As of 17 October 2025, Jyothy Labs' valuation grade has moved from attractive to very attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued. Key ratios include a PE Ratio of 31.20, an EV to EBITDA of 22.25, and a ROCE of 29.33%, which highlight its strong operational efficiency and growth potential compared to its peers. In comparison to notable competitors, Jyothy Labs' PE ratio is significantly lower than Hindustan Unilever's 57.55 and Nestle India's 83.02, both categorized as very expensive. This suggests that Jyothy Labs offers a more attractive entry point for investors in the FMCG sector. Despite recent underperformance relative to the Sensex, with a year-to-date return of -20.14% compared to the Sensex's 7.44%, the company's fundamentals indicate a strong potential for recovery and growth moving forward.